Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New European study for TheraCIM in pancreatic cancer

Nov. 23, 2004

Tarceva approved for advanced NSCLC

Nov. 22, 2004

Update on the antitumor efficacy and safety of BAY-43-9006

Nov. 22, 2004

Raf-kinase inhibitors in early development at Merck

Nov. 22, 2004

New protein kinase inhibitors prepared and tested at Roche

Nov. 22, 2004

Roche researchers describe receptor tyrosine kinase inhibitors

Nov. 22, 2004

Dosing commences in phase I study of LEraf-AON

Nov. 22, 2004

New NCI-sponsored study of GTI-2040 for prostate cancer

Nov. 22, 2004

Viventia enhances phase I bladder cancer program for Proxinium

Nov. 22, 2004

Restructuring at Tapestry

Nov. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...